Better management strategies are needed for patients with comorbid end-stage COPD and afib.
Your search for comorbidities returned 20 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Using data on patients with existing atrial fibrillation (AF), researchers analyzed the link between diabetes with the AF phenotype and cardiac and neurologic comorbidities.
Early mortality after atrial fibrillation ablation may be predicted by the occurrence of heart failure, procedural complications, as well as low hospital AF ablation.
An increased risk for stroke and SE was found among patients with newly diagnosed AF while receiving critical care compared with those without AF,
Researchers sought to determine whether screening vs no screening for atrial fibrillation could reduce morbidity and mortality.
The risk for a cardiac event was found to be greater in patients with peripheral artery disease vs coronary artery disease.
Using an IV sotalol formulation, researchers were able to develop a safe and cost-effective option for administering the antiarrhythmic drug.
Patients with atrial fibrillation who use anticoagulants and have a history of gastrointestinal bleeding may be at higher risk for subsequent major gastrointestinal bleeding.
A recent meta-analysis found there is insufficient evidence supporting the link between some forms of subclinical atrial fibrillation and an increased risk of thrombotic events.
In patients hospitalized for COPD exacerbation, the presence of atrial fibrillation may increase the risk of in-hospital mortality.